期刊文献+

纯磁性纳米四氧化三铁颗粒对肝癌和肺腺癌细胞活性的影响 被引量:3

An observation on effect of pure magnetic nanoparticles(Fe_3O_4) on human hepatoma cells and human lung adenocarcinoma cells
原文传递
导出
摘要 目的研究纯的裸露磁性纳米Fe3O4颗粒对肝癌细胞SMMC-7721和人肺腺癌细胞SPC-A-1 2种细胞活性的影响。方法2种细胞与浓度为0~0.25 mg/ml的纯磁性纳米Fe3O4颗粒培育不同时间后,利用噻唑蓝法(MTT)对细胞的活性进行检测;同时通过显微镜观察和原子吸收法分别对细胞吞噬磁性纳米颗粒的效果及其吞噬量进行分析。结果当浓度不高于100μg/ml时,未经修饰的纯磁性纳米Fe3O4颗粒不会对SMMC-7721和SPC-A-1细胞的生长产生明显抑制作用,同时SPC-A-1细胞对纳米颗粒的吞噬量也较SMMC-7721的低。结论裸露磁性纳米Fe3O4颗粒在较大浓度范围内对SMMC-7721和SPC-A-1细胞的生长和代谢无明显的影响,这为磁性纳米Fe3O4颗粒在许多生物医学领域中的应用提供了实验参考和依据。 Objective To investigate the effect of the pure magnetic Fe3O4 nanopartilces on the human hepatoma cells SMMC- 7721 and human lung adenocarcinoma cells SPC-A-1. Methods After SMMC-7721 cells and SPC-A-1 cells incubated with fresh medium containing pure magnetic Fe3O4 nanopartilces in different concentrations (range 0 -0.25mg/ml), cell viability was examined with MTT assays, and the intracellular uptake amount into cells and iron content within the cells were analyzed by microscopy and atomic absorption spectrophotometry(AAS) respectively. Results The pure magnetic Fe3O4 nanopartilces did not cause apparent effect on the growth of the SMMC-7721 and SPC-A-1 cells at the concentrations not higher than 100μg/mL, and the intracellular uptake amount into the SPC-A-1 cells was relatively lower than the SMMC-7721. Conclusion The pure magnetic Fe3O4 nanopartilces are biocompatible to the cells when they are incubated in the definite concentration, and no evidence show that there are adverse effects on the growth and metabolism of the cells. It would provide an intensive experimental foundation for the application of magnetic nanoparticles.
出处 《毒理学杂志》 CAS CSCD 北大核心 2009年第2期89-91,92,共4页 Journal of Toxicology
基金 国家自然科学基金(c03031801) 上海市优秀学科带头人计划(06XD14039)
关键词 磁性纳米颗粒 细胞 活性 Magnetic nanopartiele Cell Effect
  • 相关文献

参考文献8

  • 1Kim DK, Zhang Y, Voit W. Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles. J Magn Mater, 2001, 225:30-36.
  • 2Neuberger T, Schopf B, Hofmann H, et al. Superparamagnetic Nanoparticles for Biomedical Applications: Possibilities and Limitations of a New Drug Delivery System. J Magn Magn Mater, 2005, 293:483-496.
  • 3Wang YJ, Hussain SM, Krestin GP. Superparamagnetic Iron Oxide. Contrast Agents: Physicochemical Characteristics and Applications in MR Imaging. Eur Radiol, 2001, 11:2319- 2331.
  • 4Corot C, Petry KG, Trivedi R, et al. Macrophage imaging in the central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol, 2004, 39:619-625.
  • 5Chen KZ, Hu YH. Cytotoxic Effects of Magnetic Iron Oxide Nanoparticles on HeLa and HEK 293 Cells, Nanosci Nanotechnol, 2007, 4 : 8-11.
  • 6Gupta AK, Gupta M. Cytotoxicity Suppression and Cellular Uptake Enhancement of Surface Modified Magnetic Nanoparticles. Biomaterials, 2005, 26:1565-1573.
  • 7Berry CC, Well S, Charles S, et al. Cell Response to Dextran-derivatised Iron Oxide Nanoparticles Post Internalization. Biomaterials, 2004, 25:5405-5413.
  • 8Bourrinet P, Bengele H, Bonnemain B, et al. Preclinical safety and pharmacokinetic profile of ferumoxtran-10 an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent, Invest Radiol, 2006, 41:313-324.

同被引文献31

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部